{"entity":{"id":"nct06693375","kind":"trial","name":"To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.","aka":[],"tldr":"A phase 2 trial of Iron oxide nanoparticles in colorectal cancer, run by NanoEcho AB, now recruiting.","summary":"To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients. is a phase 2 interventional study registered as NCT06693375 by NanoEcho AB, with 12 participants planned, started 2024-10-29 and due to reach its primary completion in 2026-05. Interventions recorded: Iron oxide nanoparticles and Rectal Magnetomotoric ultrasound (MMUS).","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06693375","url":"https://clinicaltrials.gov/study/NCT06693375"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06693375","phase":"2","setting":"A Phase 2a, Exploratory, Two-Part, Open-Label Trial to Evaluate Dose and Safety of NanoEcho Particle-1 (Ferumoxtran) Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers, Part A, and Rectal Cancer Patients, Part B.","sponsor":"NanoEcho AB","enrolled":12,"outcomes":[]},"route":"/trials/nct06693375/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}]}}